Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 8 studies | 22% ± 5% | |
connective tissue cell | 4 studies | 36% ± 23% |
Insufficient scRNA-seq data for expression of P3H1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2042.73 | 226 / 226 | 100% | 18.26 | 406 / 406 |
skin | 100% | 3398.39 | 1808 / 1809 | 100% | 47.68 | 472 / 472 |
ovary | 100% | 3127.23 | 180 / 180 | 100% | 22.58 | 429 / 430 |
lung | 100% | 2947.77 | 577 / 578 | 100% | 23.00 | 1154 / 1155 |
uterus | 100% | 3069.52 | 170 / 170 | 100% | 33.22 | 457 / 459 |
breast | 100% | 2412.01 | 459 / 459 | 99% | 25.89 | 1112 / 1118 |
prostate | 100% | 2342.40 | 245 / 245 | 99% | 15.32 | 499 / 502 |
thymus | 100% | 2262.07 | 653 / 653 | 99% | 15.89 | 601 / 605 |
bladder | 100% | 2348.33 | 21 / 21 | 99% | 22.17 | 499 / 504 |
intestine | 100% | 1874.11 | 966 / 966 | 99% | 15.73 | 521 / 527 |
stomach | 99% | 1265.01 | 356 / 359 | 100% | 16.44 | 285 / 286 |
adrenal gland | 100% | 2619.53 | 258 / 258 | 98% | 16.78 | 226 / 230 |
esophagus | 99% | 1660.31 | 1429 / 1445 | 99% | 21.30 | 181 / 183 |
pancreas | 98% | 961.17 | 320 / 328 | 99% | 28.78 | 177 / 178 |
kidney | 100% | 1765.84 | 89 / 89 | 95% | 18.68 | 859 / 901 |
brain | 90% | 854.52 | 2375 / 2642 | 94% | 12.13 | 665 / 705 |
adipose | 100% | 2601.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.64 | 29 / 29 |
spleen | 100% | 3686.12 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.67 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.87 | 1 / 1 |
blood vessel | 100% | 2620.33 | 1334 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 17.52 | 79 / 80 |
heart | 98% | 1295.61 | 841 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 1191.97 | 855 / 929 | 0% | 0 | 0 / 0 |
muscle | 67% | 424.35 | 534 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0018126 | Biological process | protein hydroxylation |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0061077 | Biological process | chaperone-mediated protein folding |
GO_1901874 | Biological process | negative regulation of post-translational protein modification |
GO_0006457 | Biological process | protein folding |
GO_0050821 | Biological process | protein stabilization |
GO_0060348 | Biological process | bone development |
GO_0050708 | Biological process | regulation of protein secretion |
GO_0032963 | Biological process | collagen metabolic process |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0031418 | Molecular function | L-ascorbic acid binding |
GO_0005506 | Molecular function | iron ion binding |
GO_0005518 | Molecular function | collagen binding |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
GO_0019797 | Molecular function | procollagen-proline 3-dioxygenase activity |
Gene name | P3H1 |
Protein name | Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Growth suppressor 1) (Leucine- and proline-enriched proteoglycan 1) (Leprecan-1) Prolyl 3-hydroxylase 1 |
Synonyms | LEPRE1 PSEC0109 GROS1 |
Description | FUNCTION: Basement membrane-associated chondroitin sulfate proteoglycan (CSPG). Has prolyl 3-hydroxylase activity catalyzing the post-translational formation of 3-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens, especially types IV and V. May be involved in the secretory pathway of cells. Has growth suppressive activity in fibroblasts. . |
Accessions | ENST00000372526.2 ENST00000296388.10 [Q32P28-1] H7C2W6 ENST00000236040.8 [Q32P28-3] Q32P28 ENST00000397054.7 [Q32P28-4] E2QRI1 ENST00000431412.3 |